Open Source to be Featured at Upcoming DIA Annual Meeting

Open Source to be Featured at Upcoming DIA Annual Meeting

The Drug Information Association's 43rd Annual Meeting June 17-21, in Atlanta, GA, will feature a panel titled 'Open Source Software in GCP-Compliant Environments'. This panel will explore how institutions are looking towards open source for more transparent, standards-based systems to meet challenges of flexibility, interoperability, and cost in clinical trials.

Boston, MA (PRWEB) April 25, 2007

Akaza Research CEO Cal Collins will be leading a panel of open source software experts at the Drug Information Association's 43rd Annual Meeting June 17-21, in Atlanta, GA. The panel, titled 'Utilizing Open Source Software in GCP-Compliant Environments', will explore how institutions are looking towards open source for more transparent, standards-based systems to meet challenges of flexibility, interoperability, and cost in clinical trials. It will focus on how the collaborative open source model can be employed to meet these needs and at the same time produce robust, GCP-compliant products.

The panel will include Dr. Mark Adams of Booz Allen Hamilton and Project Manager for NCI's Cancer Biomedical Informatics Grid (caBIG) and Mark Paul, CEO of StatWorks, Inc. The panel will be held on June 19th at 8:00AM.

About OpenClinica

OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management.

OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. OpenClinica v2.0 was released in November 2006 under the GNU Lesser General Public License (LGPL). See www. OpenClinica. org.

About Akaza Research

Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www. akazaresearch. com.

MEDIA CONTACT:

Ben Baumann

Bbaumann(at)akazaresearch. com

617-621-8585 x.22

###